Trials / Completed
CompletedNCT04645979
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 153 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever. In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Online survey | Participants will be invited to complete an online questionnaire about their experience of product use. |
Timeline
- Start date
- 2020-11-11
- Primary completion
- 2020-11-27
- Completion
- 2020-11-27
- First posted
- 2020-11-27
- Last updated
- 2023-06-01
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04645979. Inclusion in this directory is not an endorsement.